 |
Monoclonal antiendotoxin antibody XMMEn-0e5 |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with gram-negative sepsis which has progressed to shock |
| USA Market Approval | USA |
| USA Designation Date | 1985-11-04 00:00:00 |
| Sponsor | Pfizer, Inc.;235 East 42nd Street;New York, New York, 10017 |
